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Abstract 8 
 9 
Accurate kinetic modelling of in vivo physiological function using positron emission tomography 10 
(PET) requires determination of the tracer time-activity curve in plasma, known as the arterial input 11 
function (AIF). The AIF is usually determined by invasive blood sampling methods, which are 12 
prohibitive in murine studies due to low total blood volumes. Extracting AIFs from PET images is 13 
also challenging due to large partial volume effects (PVE). We hypothesise that in combined PET 14 
with magnetic resonance imaging (PET/MR), a co-injected bolus of MR contrast agent and PET 15 
ligand can be tracked using fast MR acquisitions. This protocol would allow extraction of a MR AIF 16 
from MR contrast agent concentration-time curves, at higher spatial and temporal resolution than an 17 
image-derived PET AIF. A conversion factor could then be applied to the MR AIF for use in PET 18 
kinetic analysis. This work has compared AIFs obtained from sequential DSC-MRI and PET with 19 
separate injections of gadolinium contrast agent and 
18
F-FDG respectively to ascertain the technique’s 20 
validity. An automated voxel selection algorithm was employed to improve MR AIF reproducibility. 21 
We found that MR and PET AIFs displayed similar character in the first pass, confirmed by gamma 22 
variate fits (p<0.02). MR AIFs displayed reduced PVE compared to PET AIFs, indicating their 23 
potential use in PET/MR studies. 24 
 25 
1. Introduction 26 
 27 
Positron emission tomography (PET) is a quantitative imaging technique with very high 28 
sensitivity and specificity, making it ideally suited to functional investigations of tissue metabolism. 29 
Image quantitation can be performed using standard uptake values (SUVs) [1], but more accurate, 30 
relevant parameters can be obtained with compartmental modelling of tracer kinetics [2].  Although 31 
these models differ in complexity depending on the tracer used, all require knowledge of an arterial 32 
input function (AIF) to extract accurate rate constants linking the compartments. The AIF is defined 33 
as the tracer time activity-curve (TAC) in arterial plasma and is ideally measured from an artery 34 
feeding the ROI. This measurement can be performed clinically via invasive blood sampling (e.g. ~1-35 
2ml samples throughout the scan) or non-invasively by extracted an activity time course from arterial 36 
voxels on dynamic PET images. 37 
In preclinical imaging, however, the low total blood volume (e.g. ~2ml in mice [3]) requires 38 
specialist equipment [4-6] to extract blood samples safely and even then may disturb the system under 39 
measurement.  Non-invasive methods are therefore preferred, although the small size of the mouse 40 
makes it difficult to place an ROI in the blood pool of the heart [4]. Furthermore, partial volume 41 
effects (PVE) contaminate the measurements, typically reducing the peak height and increasing the 42 
width of the AIF peak [7]. As yet, no consensus has been achieved in preclinical studies for the 43 
extraction of image-derived AIFs accurately and reliably. 44 
Simultaneous PET/MR can be used to combine the comparatively high temporal and spatial 45 
resolution of dynamic MRI imaging to assist in non-invasive AIF extraction from dynamic PET. We 46 
hypothesise that a co-injected bolus of MR contrast agent and PET ligand can be tracked with fast MR 47 
acquisitions. This protocol would allow extraction of a MR AIF from MR contrast agent 48 
concentration-time curves which could then be converted to a PET AIF for use in kinetic analysis. 49 
The concentration-time curve of a gadolinium-based MR contrast agent has previously been used 50 
to model PET tracer TACs in plasma [8]. The MR and PET AIFs analysed by Poulin et al. were found 51 
to adopt a similar shape in the first pass but diverge in the long decay phase. The conversion between 52 
MR and PET AIFs therefore had to be conducted via empirically-derived factors for the rodent cohort. 53 
In the present study, we have focused on the first pass bolus of the tracer to ascertain how similar 54 
the contrast agent and tracer curves are between modalities in the initial injection phase. Echo planar 55 
imaging (EPI) sequences have been used in a dynamic susceptibility contrast (DSC)-MRI protocol [9] 56 
to detect the passage of contrast agent through murine arteries and veins via a change in the R2* 57 
relaxation parameter, which is proportional to the change in gadolinium-based contrast agent.   58 
It is difficult, however, to reliably identify blood vessel voxels in DSC-MRI due to the low SNR 59 
of EPI acquisitions. Manually selecting voxels to extract an AIF is therefore vulnerable to human 60 
error and low reproducibility [10]. Automatic AIF determination algorithms have been developed to 61 
solve this problem [11-13] and an application of one such algorithm on the DSC-MRI data is 62 
presented here. This work hopes to give an indication of whether first pass MR data can be used to 63 
improve PET AIF determination and subsequently increase the accuracy of PET kinetic analysis. 64 
 65 
2. Materials and Methods 66 
 67 
Sequential PET and MRI Four mice were imaged sequentially using DSC-MRI on a 4.7T Bruker 68 
Biospin 47/40 scanner and dynamic PET on the Cambridge Split Magnet PET/MR scanner  [14-15]. 69 
A bolus of 0.3mM/kg gadolinium contrast agent (Gd-BT-D03A) bolus was administered to each 70 
mouse via the cannulated tail vein 10s into a 100s single shot GE-EPI sequence (TR/TE 250/9ms, 71 
spatial resolution 110×200μm2, 5 slices, thickness 1.5mm, 400 frames, 100s acq. time). The animal 72 
bed was then transferred to the Focus 120 PET camera housed in the PET/MR scanner and a 10 73 
minute transmission scan performed with a 
68
Ge source. A second injection of 30MBq 
18
F-FDG was 74 
then injected through the same tail vein cannula. A 1 hour dynamic PET emission acquisition in 75 
listmode was reconstructed as dynamic data frames (3D FBP: 30x1s, 30x5s, 12x10s and 11x300s) 76 
with randoms, dead time, decay, detector efficiency, scatter and attenuation corrections applied. The 77 
scanner spatial resolution was 1.8mm isotropic (FWHM) at the centre of the FOV. The reconstructed 78 
image dimensions were 128×128×95, with an in plane resolution of 0.866mm and a slice thickness of 79 
0.796mm.  Figure 1 depicts the imaging protocol for each mouse. 80 
 81 
INSERT FIGURE 1 (1.5 column width) 82 
 83 
Automated MR arterial voxel selection A progressive voxel inclusion scheme [16-18] utilising 84 
prior knowledge of arterial positioning was applied to each mouse DSC dataset.  A database of 85 
angiography scans was used to create a voxelwise probability map for murine blood vessels 86 
(256×256×128, isotropic resolution 250μm, thickness 0.2mm). The processing and transformation of 87 
the prior knowledge map into mouse native space is shown in Figure 2. This map was transformed to 88 
each subject using the SPMmouse toolbox [19]. 89 
 90 
INSERT FIGURE 2 (1 column width) 91 
 92 
A rectangular ROI which encompassed the posterior cerebral artery (PCA) was selected as a 93 
starting point for an iterative voxel selection algorithm. AIF characteristics were ranked and starting 94 
threshold values determined empirically for each parameter. The algorithm applied the following 95 
steps to the MR contrast agent concentration-time curves: 96 
Step 1) Select voxels in ROI with rise time <3s 97 
Step 2) Peak height > 90
th
 percentile 98 
Step 3) Area under the curve (AUC) >10
th
 percentile and first moment <50
th
 percentile 99 
Step 4) FWHM < 50
th
 percentile 100 
Prior knowledge from the vascular atlas was then applied, selecting voxels with a probability >0.2 101 
of being a major blood vessel. The thresholding method was then re-applied, iteratively adjusting the 102 
threshold values (e.g. changing 90
th
 to 95
th
 percentile for peak height threshold) for each mouse until 103 
<10 voxels remained. The application of this algorithm is illustrated in Figure 3. 104 
 105 
INSERT FIGURE 3 (2 column width) AND FIGURE 4 (1 column width) 106 
 107 
AIF comparison MR AIFs were extracted as the mean signal from 5 voxels with the largest signal 108 
heights which survived all thresholds. For the PET data, a volume of interest (VOI) for the left 109 
ventricle was drawn on the final frame of each dataset using a manually seeded growth algorithm in 110 
the ASIPro software provided with the scanner (Siemens Medical Solutions, USA, Inc., Knoxville, 111 
TN, USA). These VOIs were projected onto all frames and PET AIFs were extracted as the mean 112 
signal from the VOI in each frame, as shown in Figure 4. 113 
PET and MR AIFs were compared by aligning the flush peaks of the curves and normalizing the 114 
areas under curves (AUC) for the first 90s or setting the peak heights to 1. MR AIF data was also 115 
averaged into the PET temporal resolution and compared to the PET curves. 116 
 117 
3. Results 118 
 119 
Arterial voxel detection Automatic voxel selection method provided AIFs with more consistent 120 
peak heights and curve shapes, compared to manual selection. The MR AIF data was analysed to give 121 
estimates of relative CBF, CBV and MTT [9]. The distribution patterns of rCBF and rCBV agreed 122 
with literature, as well as the mean absolute MTT values (this study: 6.6 ± 3.1s, DSC-MRI cohort of 123 
additional 19 WT mice (data not shown): 5.9 ± 1.3s, literature: 6.3 ± 1.5s) [20-21].  This validated the 124 
MR image derived input functions as suitable AIF estimates. 125 
Curve Comparisons Gamma variate fits were successfully performed on both MR and PET AIFs 126 
and are shown in Figure 4 for the AUC normalization. Goodness of fit was confirmed with p values 127 
<0.02 using the Chi-squared test. Increased agreement between the curves (see Figure 5) was seen as 128 
the peak height of the MR AIFs was reduced after averaging the MR AIF data into the PET temporal 129 
resolution. Figure 6 shows the MR (6(a)) and PET (6(b)) AIFs for all 4 mice, as well as the MR AIFs 130 
averaged into the PET temporal resolution (6(c)). A comparison of the population (mean) MR and 131 
PET AIFs in the PET temporal resolution is shown in Figure 6(d). 132 
 133 
INSERT FIGURE 5 (1.5 column width) AND FIGURE 6 (1.5 column width) 134 
 135 
4. Discussion 136 
 137 
The MR AIFs show that preclinical AIFs are improved in a similar manner to clinical AIFs if 138 
voxel selection is automated [11-13]. The decreased variation in the MR AIFs after application of 139 
prior knowledge derived from angiography recommends the use of the algorithm in future studies. 140 
Whilst similar shapes are confirmed in the first pass by fitting gamma variate functions, the peaks 141 
of the first pass were much taller and thinner from the MR AIFs when compared to the PET AIFs in 142 
the AUC normalization. This was confirmed by the peak height normalization, where the tails of the 143 
PET curves remained at a much higher level over the course of the scan. Both normalizations show 144 
similar arterial characters in the peak region but differences seen between the curves appear 145 
characteristic of PVE in the PET data. This difference was still observed if the MR data (0.25s 146 
resolution) were smoothed into the PET temporal resolution of 1s. The difference between the curves 147 
was attributed to contaminating the AIF with tissue TACs, resulting in the apparent lower peak height. 148 
Whilst these results are encouraging, it must be noted that there was variability between the PET 149 
curves due to different volumes of tracer being injected and additional variability in both sets of 150 
curves due to manual administrations of the bolus injections. These obstacles could be avoided in 151 
future experiments with a syringe pump and a co-injection of tracer and contrast agent to ensure that 152 
the MR and PET protocols truly measure the same AIF. Ideally this should be conducted on a 153 
simultaneous PET/MR scanner. 154 
 155 
5. Conclusions 156 
 157 
Image derived first pass bolus AIFs derived from sequential PET/MR were found to be of similar 158 
character. The data suggest that MR AIFs are more precise due to reduced PVE. We are confident that 159 
they can be used in simultaneous PET/MR once appropriate scaling factors have been derived via 160 
blood sampling. 161 
 162 
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 213 
Figure Captions 214 
 215 
Figure 1: Sequential PET/MR protocol outline. Injections conducted from outside magnet bore via tail 216 
vein cannula. TRX = transmission scan, AC = attenuation correction 217 
 218 
Figure 2:  Probabilistic vascular atlas. (A) Sample mouse brain TOF angiography scan, which is co-219 
registered to common space template in SPMmouse using T2w anatomical scans to compute 220 
transformation matrix. (B) Normalization in common space to create probabilistic map of vessel 221 
positions. (C) Inverse transformation of prior knowledge information into subject space. 222 
 223 
Figure 3: Workflow of automated algorithm, incorporating iterative thresholding and prior knowledge 224 
to estimate the MR AIF. 225 
 226 
Figure 4:  Axial PET image of mouse heart (left), with blood pool VOI used for AIF extraction 227 
highlighted in yellow. A magnified (×10) image is shown on the right. 228 
 229 
Figure 5: Individual mouse PET and MR image-derived AIF comparison. Gamma variate fits (left) to 230 
PET and MR curves (AUC normalization) indicate similar bolus shapes. Reducing the temporal 231 
resolution of the MR AIF to that of the PET AIF (right) by smoothing shows increased agreement 232 
between the curves. 233 
 234 
Figure 6: AIFs for 4 mice using AUC normalization (a) MR, (b) MR smoothed into PET space and (c) 235 
PET. Population AIFs for (b) and (c) are compared in (d), error bars indicate one standard deviation. 236 
